The global humanized mouse model market is projected to be valued at USD 101.5 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2033, reaching USD 178.3 million by the end of the forecast period.
One of the key factors propelling this growth is the rising demand for more comprehensive screening of novel drug candidates, particularly in the treatment of chronic diseases such as cardiovascular conditions, diabetes, and cancer. Humanized mouse models play a crucial role in providing more accurate insights into human biology, making them essential tools in preclinical research and drug development.
The market has already demonstrated consistent growth, recording a CAGR of 5.3% from 2017 to 2022. This momentum is expected to continue as pharmaceutical companies, research institutions, and healthcare organizations increasingly adopt humanized models to expedite the development of effective treatments.
The healthcare sector’s focus on improving therapies for chronic diseases, which remain leading causes of morbidity and mortality worldwide, is anticipated to further drive market expansion. Humanized mouse models enable researchers to simulate human disease conditions more accurately, making them indispensable in drug discovery and development processes.
The use of genetically modified mice in experimental medical research has resulted in significant advances in disease understanding and human health. The manipulation of the mouse genome has become more refined with the development of gene targeting and transgenic methods, as well as recent advances in gene-editing technologies. Humans and mice share a great deal of genetic similarity; however, it is also recognised that even minor sequence differences between the two species can have significant functional consequences for the respective individual gene functions.
Key Players
The writer will create content on the general strategies of market players. And then will write the key players in the market are: Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc., Genoway S.A., Crown Bioscience Inc., Taconic Biosciences Inc., The Jackson Laboratory, and Vitalstar Biotechnology Co. Ltd.
Segmentation
The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:
By model type, the Global Humanized Mouse Model Industry can be segmented into,
- Genetic Humanized Mouse Model
- Cell-based Humanized Mouse Model
- CD34
- PBMC
- BLT
By application, the Global Humanized Mouse Model Industry can be segmented into,
- Oncology
- Immunology and Infectious Diseases
- Neuroscience
- Toxicology
- Hematopoiesis
- Others
By end user, the Global Humanized Mouse Model Industry can be segmented into,
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutions
Product Segmentation
The investigation offers a top to bottom evaluation of different clients’ journeys pertinent to the market and its segments. The study endeavours to assess the current and future development possibilities, undiscovered roads, factors that shapes their income potential in the global market by breaking it into di such as its types, applications, and region-wise assessment.
Full in-depth analysis of the parent market
The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.
Important changes in market dynamics
The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.
Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
